Ingalls & Snyder LLC boosted its stake in MEDIFAST INC (NYSE:MED) by 14.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 82,227 shares of the specialty retailer’s stock after buying an additional 10,247 shares during the period. Ingalls & Snyder LLC’s holdings in MEDIFAST INC were worth $3,410,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. Chicago Equity Partners LLC boosted its stake in shares of MEDIFAST INC by 0.3% in the first quarter. Chicago Equity Partners LLC now owns 17,370 shares of the specialty retailer’s stock valued at $771,000 after buying an additional 50 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in shares of MEDIFAST INC by 1.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,173 shares of the specialty retailer’s stock valued at $230,000 after buying an additional 91 shares during the period. Arizona State Retirement System boosted its stake in shares of MEDIFAST INC by 1.8% in the first quarter. Arizona State Retirement System now owns 5,813 shares of the specialty retailer’s stock valued at $258,000 after buying an additional 100 shares during the period. HL Financial Services LLC boosted its stake in shares of MEDIFAST INC by 1.5% in the first quarter. HL Financial Services LLC now owns 8,088 shares of the specialty retailer’s stock valued at $359,000 after buying an additional 119 shares during the period. Finally, Mason Street Advisors LLC boosted its stake in shares of MEDIFAST INC by 7.0% in the first quarter. Mason Street Advisors LLC now owns 2,604 shares of the specialty retailer’s stock valued at $116,000 after buying an additional 170 shares during the period. 91.90% of the stock is currently owned by institutional investors and hedge funds.
Shares of MEDIFAST INC (MED) opened at 42.40 on Friday. The stock’s 50 day moving average price is $41.69 and its 200 day moving average price is $43.12. The stock has a market capitalization of $505.70 million, a PE ratio of 25.85 and a beta of 0.48. MEDIFAST INC has a one year low of $34.64 and a one year high of $47.35.
MEDIFAST INC (NYSE:MED) last issued its quarterly earnings results on Thursday, May 4th. The specialty retailer reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.49 by $0.02. The firm had revenue of $70.62 million for the quarter, compared to analyst estimates of $72.36 million. MEDIFAST INC had a return on equity of 24.94% and a net margin of 7.23%. The business’s revenue was down 2.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.42 earnings per share. Equities research analysts predict that MEDIFAST INC will post $2.02 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 9th. Stockholders of record on Friday, June 23rd will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 3.02%. The ex-dividend date of this dividend is Wednesday, June 21st. MEDIFAST INC’s dividend payout ratio is presently 77.58%.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://stocknewstimes.com/2017/08/05/ingalls-snyder-llc-purchases-10247-shares-of-medifast-inc-med.html.
Separately, Sidoti cut MEDIFAST INC from a “buy” rating to a “neutral” rating in a report on Tuesday, May 2nd.
MEDIFAST INC Company Profile
Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.
Want to see what other hedge funds are holding MED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDIFAST INC (NYSE:MED).
Receive News & Ratings for MEDIFAST INC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDIFAST INC and related companies with MarketBeat.com's FREE daily email newsletter.
